Session 50

 

Tuesday, September 5
8:00 – 10:00 am

Room 18

 

 

Oral presentations (7): Oncology – Part I

Chair: Jan Martinek (Czech Republic)

 

089 Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer.

Qi-Xin Shang; Long-Qi Chen

West China Hospital of Sichuan University, China

 

090 PTTG1 promotes epithelial-mesenchymal transition and metastasis of esophageal squamous cell cancer via GLI1 signaling pathway.

Feng Wang; Qingxia Fan

The First Affiliated Hospital Of Zhengzhou University, China

 

091 Activation of NRF2 pathway is associated with worse prognosis of esophageal squamous cell carcinoma.

Xiaozheng Kang1; Luyan Shen1; Yangyang Guo1; Bin Dong1; Xiaoxin Chen2; Ke-Neng Chen1

1) Peking University Cancer Hospital, China; 2) North Carolina Central University, USA

 

092 High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma.

Han-Yu Deng1; Yi-Dan Lin2; Long-Qi Chen2

1) West China Hospital/West China School of Medicine, Sichuan University, China; 2) West China Hospital, Sichuan University, China

 

093 Examined lymph node stations: revised guidance for adequate staging during surgery for esophageal squamous cell carcinoma.

Xiayu Fu; Kongjia Luo; Hong Yang; Xiinye Wang; Peng Lin; Jianhua Fu

Sun Yat-sen University Cancer Center, China

 

094 Impact of negative lymph node station count on the long-term survival of resected esophageal squamous cell carcinoma.

Xiayu Fu; Qianwen Liu; Hong Yang; Peng Lin; Jianhua Fu

Sun Yat-sen University Cancer Center, China

 

095 A novel blood marker of tumor progression and prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin Ratio.

Zihui Tan

Sun Yat-sen University Cancer Center, China

 

096 Esophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score matched study.

Yidan Lin; Hanyu Deng; Yang Hu

West China Hospital of Sichuan University, China

 

097 Disputed issues in the treatment and ongoing research projects for esophageal cancer in China.

Yousheng Mao1; Tie-hua Rong2; Shugeng Gao1; Yin Li3; Jing Huang1; Ze-fen Xiao1

1) Cancer Hospital, Chinese Academy of Medical Sciences, China; 2) Sun Yan-sen University Cancer Center, Sun Yan-sen University, Guangzhou, China; 3) Henan Cancer Hospital, Zhengzhou, China

 

098 miR-302b regulates cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.

Mingxin Zhang1; Lingmin Zhang2; Manli Cui1; Suna Zhou3; Jingjie Wang1; Chao Zhang1

1) Department of Gastroenterology, Tangdu Hospital, Fourth Military Medical University, China; 2) Department of Anesthesiology, First Affiliated Hospital, Xi’an Jiaotong University, China; 3) Department of Radiotherapy, Tangdu Hospital, Fourth Military Medical University, China

 

099 Esophageal histological precursor lesions and subsequent risk of esophageal squamous cell carcinoma: a 10-year follow-up study in high risk populations.

Chen-Tao Guan1; Wen-Qiang Wei1; You-Lin Qiao1; Meng Wang1; Sanford Dawsey2; Guo-Hui Song3

1) National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China; 2) National Cancer Institute, NIH, USA; 3) Cancer Institute/Hospital of Ci County, China

 

100 Synchronous esophageal neoplasia among head and neck cancer patients: endoscopy surveillance, risk factors, and outcome analysis.

I-Chen Wu; I-Chen Wu; Ming-Tsang Wu

Kaohsiung Medical University and Kaohsiung Medical University Hospital, Taiwan

 

101 Study on relationship between extranodal extension of lymph node with prognostic factors in esophageal squamous cell carcinoma.

Feng Wang; Danjie Chen; Qingxia Fan

The First Affiliated Hospital of Zhengzhou University, China

 

102 Clinical outcomes of gastric cardia cancer during a recent decade of Korea.

Sooa Choi; Woo Chul Chung; Yeon-Ji Kim

The Catholic University of Korea, South Korea

 

103 “Withdrawn abstract”

 

104 A non-interventional study on circumferential resection margin for patients with pathological T3N0M0 thoracic esophageal carcinoma.

Yu-Shang Yang; Long-Qi Chen; Qi-Xin Shang

West China Hospital of Sichuan University, China

 

105 Esophageal adenocarcinoma in patient younger than 45 Years: experience from a tertiary care center in Croatia.

Petra Jurcic; Marko Nikolic; Ivan Budimir; Ivana Pavic; Dominik Kralj

Clinical Hospital Center Sestre Milosrdnice, Croatia

 

106 Prognostic factors and management in primary esophageal small cell carcinoma.

Zihui Tan

Sun Yat-sen University Cancer Center, China

 

107 Surgical management of patients with limited metastatic gastric and esophagogastric junction cancer: the FLOT 3 trial.

Mickael Chevallay1; Salah-Eddin Al-Batran2; Stefan Mönig1

1) HUG, Switzerland; 2) Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Germany

 

108 Effect of chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The RENAISSANCE Trial (FLOT 5).

Mickael Chevallay1; Salah-Eddin Al-Batran2; Thorsten Götze2; Stefan P. Mönig1

1) HUG, Switzerland; 2) Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, Germany